SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001566044-21-000025
Filing Date
2021-05-06
Accepted
2021-05-06 08:46:10
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vyne-20210331.htm   iXBRL 10-Q 1006992
2 EX-10.1 exhibit101saik-vyneemploym.htm EX-10.1 108905
3 EX-10.2 exhibit102harsch-vyneemplo.htm EX-10.2 106605
4 EX-31.1 vyne-20210331xexx311.htm EX-31.1 9697
5 EX-31.2 vyne-20210331xexx312.htm EX-31.2 9685
6 EX-32.1 vyne-20210331xexx321.htm EX-32.1 5272
7 EX-32.2 vyne-20210331xexx322.htm EX-32.2 5257
13 vyne1a.jpg GRAPHIC 7912
  Complete submission text file 0001566044-21-000025.txt   5869989

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20210331.xsd EX-101.SCH 45592
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20210331_cal.xml EX-101.CAL 77383
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20210331_def.xml EX-101.DEF 260395
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20210331_lab.xml EX-101.LAB 583096
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20210331_pre.xml EX-101.PRE 388451
14 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20210331_htm.xml XML 761631
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 21896068
SIC: 2834 Pharmaceutical Preparations